Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
for selecting the most qualified candidates. See this link for further information about shortlisting at the Faculty of Arts: shortlisting Faculty of Arts The Faculty of Arts is one of five main academic areas
-
. Starting date is 1 January 2026 (or according to mutual agreement). The position is a full-time position. You can read more about career paths at DTU here . Further information Further information may be
-
(e.g. western blotting, IHC, etc.) is preferred. Prior experience with primary cell isolation and organoids is preferred. Further information Further information can be obtained by e-mail to professor
-
candidates. See this link for further information about shortlisting at the Faculty of Arts: shortlisting Faculty of Arts The Faculty of Arts is one of five main academic areas at Aarhus University
-
of very large data sets, data analysis, and simulations of X-ray scattering and spectroscopy signatures of dynamic processes in battery materials. The theoretical/ simulation efforts are supported by
-
later than 1 March 2026. The position is a full-time position. You can read more about career paths at DTU here . Further information Further information may be obtained from Professor Adriano Sciacovelli
-
This post is partly funded by the ‘ADD – Algoritmer, Data & Demokrati’ project funded by the Velux and Villum Foundations. This project is led by Professor Nørholm Sine Just at Roskilde University
-
. The allowance will be agreed upon with the relevant union. The period of employment is one year. Starting date is as early as possible. You can read more about career paths at DTU here . Further information
-
and reduction of very large data sets, data analysis, and simulations of X-ray scattering and spectroscopy signatures of dynamic processes in battery materials. The theoretical/ simulation efforts
-
or as soon as possible thereafter You can read more about career paths at DTU here . Further information En’Zync is a visionary research center led by Prof. Daniel Otzen, funded by the Novo Nordisk